在癌症中向蛋白质氨基甲基转移酶 (PRMT) 的现有和新兴疗法
Adriana Kaganovski1, Bayle Smith-Salzberg1, Hadar K Shimshon1
1College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA.
International journal of molecular sciences
|August 28, 2025
概括
蛋白质阿基因甲基转移酶 (PRMT) 调节基因表达和细胞过程. 这一审查突出了PRMTs
科学领域:
- 表观遗传学和分子生物学
- 癌症研究
- 药理学
背景情况:
- 蛋白质氨基甲基转移酶 (PRMT) 是催化氨基甲基化酶,这是一个关键的翻译后修饰.
- PRMT 作为影响基因表达,信号转导和细胞增殖的表观遗传调节剂.
- 异常的PRMT活性与各种癌症的进展有关,包括乳腺癌,肺癌和结直肠癌,往往与预后不佳有关.
研究的目的:
- 审查个别PRMT在癌症发展和进展中的具体作用.
- 突出PRMT抑制剂作为潜在治疗剂的最新进展.
- 强调在瘤学中针对PRMT的治疗潜力.
主要方法:
- 在癌症中对PRMT进行临床前和临床研究的综合文献综述.
- 对各种癌症类型中PRMTs失调的研究分析.
- 评估新型PRMT抑制剂的疗效和治疗潜力.
主要成果:
- 在癌症中,PRMTs扮演着不同的角色,它们的失调有助于瘤形成.
- 在临床前和临床研究中,许多针对PRMT活性的新型化合物已显示出显著的治疗效果.
- 在多种癌症类型中,PRMT过度表达与较差的患者结局有关.
结论:
- 在癌症中,PRMT是关键的调节剂,使其成为有希望的治疗点.
- 新兴的PRMT抑制剂对癌症治疗具有显著的潜力.
- 为了充分阐明PRMT在瘤学中的治疗效用,需要进行进一步的研究.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K